Related Experiment Videos
Prostate Cancer Stem Cells and Nanotechnology: A Focus on Wnt Signaling
Wei Qin1, Yongjiang Zheng2, Bin-Zhi Qian3
1The Third Affiliated Hospital, Zhongshan School of Medicine, Sun Yat-sen UniversityGuangzhou, China; Key Laboratory for Stem Cells and Tissue Engineering, Ministry of Education, Sun Yat-sen UniversityGuangzhou, China.
Abstract:
Prostate cancer is the most common cancer among men worldwide. However, current treatments for prostate cancer patients in advanced stage often fail because of relapse. Prostate cancer stem cells (PCSCs) are resistant to most standard therapies, and are considered to be a major mechanism of cancer metastasis and recurrence. In this review, we summarized current understanding of PCSCs and their self-renewal signaling pathways with a specific focus on Wnt signaling. Although multiple Wnt inhibitors have been developed to target PCSCs, their application is still limited by inefficient delivery and toxicity in vivo. Recently, nanotechnology has opened a new avenue for cancer drug delivery, which significantly increases specificity and reduces toxicity. These nanotechnology-based drug delivery methods showed great potential in targeting PCSCs. Here, we summarized current advancement of nanotechnology-based therapeutic strategies for targeting PCSCs and highlighted the challenges and perspectives in designing future therapies to eliminate PCSCs.
Insights
Prostate cancer stem cells (PCSCs) drive recurrence. Nanotechnology offers promising strategies to target these therapy-resistant cells, improving treatment efficacy for advanced prostate cancer.
Area of Science:
- Oncology
- Nanomedicine
- Stem Cell Biology
Background:
- Prostate cancer is a leading global cancer in men, with advanced stages often experiencing treatment failure and relapse.
- Prostate cancer stem cells (PCSCs) are implicated in therapeutic resistance, metastasis, and recurrence.
- Wnt signaling is a key pathway regulating PCSC self-renewal.
Purpose of the Study:
- To review current knowledge on PCSCs and their self-renewal pathways, particularly Wnt signaling.
- To explore the potential of nanotechnology-based drug delivery systems for targeting PCSCs.
- To highlight advancements, challenges, and future perspectives in developing nanotechnology-based therapies against PCSCs.
Main Methods:
- Literature review summarizing research on PCSCs, Wnt signaling, and nanotechnology applications in cancer therapy.
- Analysis of current nanotechnology-based drug delivery strategies for targeting PCSCs.
- Discussion of challenges and future directions for PCSC-targeted therapies.
Main Results:
- PCSCs are a significant factor in prostate cancer relapse and metastasis.
- Wnt signaling pathways are crucial for PCSC self-renewal.
- Nanotechnology demonstrates potential for enhanced, targeted delivery of therapeutics to PCSCs, reducing toxicity.
Conclusions:
- Targeting PCSCs is essential for overcoming treatment resistance and preventing recurrence in advanced prostate cancer.
- Nanotechnology-based drug delivery systems offer a promising approach to effectively target and eliminate PCSCs.
- Further research and development are needed to overcome challenges and realize the full therapeutic potential of these strategies.